Javier Arbizu Lostao-rekin lankidetzan egindako argitalpenak (8)

2019

  1. Erratum: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience (PLoS ONE (2019)14:6 (e0217881)Doi:10.1371/journal.pone.0217881)

    PLoS ONE

  2. Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience

    PLoS ONE, Vol. 14, Núm. 6

2012

  1. Tomografía por emisión de positrones en tumores del sistema nervioso central

    Medicina nuclear en la práctica clínica (Aula Médica Ediciones), pp. 769-778

2011

  1. Voxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineation

    Journal of Nuclear Medicine, Vol. 52, Núm. 6, pp. 865-872

2010

  1. Safety and efficacy assessment of flow redistribution by occlusion of intrahepatic vessels prior to radioembolization in the treatment of liver tumors

    CardioVascular and Interventional Radiology, Vol. 33, Núm. 3, pp. 523-531

2008

  1. Liver disease induced by radioembolization of liver tumors: Description and possible risk factors

    Cancer, Vol. 112, Núm. 7, pp. 1538-1546

1999

  1. C-11-methionine and F-18-FDG PET in gliomas: A semiquantitative study in the pretherapeutic and posttherapeutic evaluation.

    EUROPEAN JOURNAL OF NUCLEAR MEDICINE

  2. Could <SUP>11</SUP>C-methionine avoid the use of <SUP>18</SUP>F-fluoro-deoxyglucose in brain Pet imaging of gliomas

    11TH EUROPEAN CONGRESS OF NEUROSURGERY